News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
146 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (24320)
Month
January (2882)
February (2030)
March (1769)
April (2200)
May (2664)
June (3161)
July (3087)
August (3800)
September (4259)
October (5135)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
Deals
Aviragen and Vaxart Amend Terms of Merger Agreement to Increase the Value for Aviragen Stockholders
Under the new terms, Aviragen stockholders would now own 49% of the combined company, up from 40% under the previous agreement.
February 8, 2018
·
9 min read
Drug Development
ArmaGen’s AGT-181 Demonstrates Neurocognitive Benefit in Children With Severe MPS I
On a somatic level, AGT-181 stabilized urinary glycosaminoglycans, reduced liver and spleen volume including in patients previously exposed to laronidase, and further improved shoulder range of motion.
February 8, 2018
·
7 min read
Biotech Beach
GenomeDx Biosciences’ Decipher Tests and Decipher GRID to be Featured in Multiple Presentations at 2018 Genitourinary Cancers Symposium
The 2018 GU Cancers Symposium is the premier scientific and educational meeting .
February 8, 2018
·
6 min read
Business
Newron Pharmaceuticals S.p.A. Announces Change in the Board of Directors
Newron today announced that Bo Jesper Hansen has informed the Board of Directors of his intention to step down as a Non-Executive Director, effective from this year’s Annual Shareholders Assembly taking place on March 27, 2018.
February 8, 2018
·
5 min read
Pharm Country
UBM Release: Pharmapack Europe Award Winners 2018 21 Years Dedicated to the Industry’s Biggest Innovation
BIOCORP, West Pharmaceutical Services, Inc. & sfm medical devices GmbH win prestigious ‘Exhibitor Innovation’
February 8, 2018
·
4 min read
Business
IMRIS Reports Continued Strong Growth in 2017
Due to continued business growth, IMRIS has expanded the organization incrementally with the addition of more than 25 new personnel in the past 12 months.
February 8, 2018
·
3 min read
Biotech Bay
California Life Sciences Association Recognizes Senator Patricia Bates and Assemblymembers Heath Flora, Rob Bonta as Champions of Biomedical Innovation
California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, honored three California state legislators as Life Sciences Champions during its Back to Session Reception in Sacramento that took place on February 7.
February 8, 2018
·
3 min read
Deals
Bay Area Medical Device Firm Acquires Corpus Medical
Confluent Medical Technologies completed the acquisition of Corpus Medical. Confluent Medical is a contract manufacturer with full scale capabilities to provide high-quality, low cost finished class III medical devices.
February 8, 2018
·
4 min read
BioMidwest
AptarGroup and Adapt Pharma Donate NARCAN Nasal Spray to Opioid Crisis Coalitions in Illinois
AptarGroup and Adapt Pharma today announced a joint donation of 4,000 doses of NARCAN® to Illinois Governor Bruce Rauner’s Opioid Overdose Prevention and Intervention Task Force, with another 1,000 doses scheduled to go to the McHenry County Substance Abuse Coalition Friday.
February 8, 2018
·
5 min read
Biotech Bay
Adverum Biotechnologies Announces Proposed Public Offering of Common Stock
The offering is subject to market and other conditions, and there can be no assurances as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
February 8, 2018
·
3 min read
Previous
11 of 15
Next